The current role of secondary cytoreductive surgery for recurrent ovarian cancer.

MLA

de Bree, Eelco, et al. “The Current Role of Secondary Cytoreductive Surgery for Recurrent Ovarian Cancer.” Frontiers in Oncology, vol. 12, Oct. 2022, pp. 1–12. EBSCOhost, https://doi.org/10.3389/fonc.2022.1029976.

APA

de Bree, E., Michelakis, D., & Anagnostopoulou, E. (2022). The current role of secondary cytoreductive surgery for recurrent ovarian cancer. Frontiers in Oncology, 12, 1–12. https://doi.org/10.3389/fonc.2022.1029976

Chicago

de Bree, Eelco, Dimosthenis Michelakis, and Elisavet Anagnostopoulou. 2022. “The Current Role of Secondary Cytoreductive Surgery for Recurrent Ovarian Cancer.” Frontiers in Oncology 12 (October): 1–12. doi:10.3389/fonc.2022.1029976.